BUSINESS REGISTRATION NUMBER
BRN 68100579

NT Pharma Pacific Company Limited

泰凌醫藥(亞洲)有限公司

Registry Verified: 2026-10-09
Inquiries: 110 Views
Jurisdiction: Hong Kong, China

NT Pharma Pacific Company Limited (泰凌醫藥(亞洲)有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 2569596, and Business Registration Number (BRN) is 68100579. Incorporated on 2017-08-22, the entity has maintained continuous statutory operations for 9 years and 2 months, currently holding an active legal status of Live. The registered office is situated at ROOM 2102, 21/F, SHUN TAK CENTRE, 168-200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), its annual return filing window falls between Aug 22 – Oct 03 (within 42 days after its incorporation anniversary), with the latest Annual Return (Form NAR1) officially filed on 2026-08-25; a total of 24 statutory filings (spanning 2017–2026, latest filed on 2026-08-25) are indexed in the registry, comprising 9 Annual Return(s) (NAR1), 8 officer/secretary change notice(s) (ND2A), 3 registered office change(s) (NR1). In terms of judicial records, Hong Kong court registers show 1 public court dockets associated with this corporation (no compulsory winding-up petitions on file; detailed case dockets are archived in the due diligence report).

I. Corporate Profile & Statutory Registry Records

Official Chinese Name 泰凌醫藥(亞洲)有限公司 Official English Name NT Pharma Pacific Company Limited
Company Reg No. (CRN) 2569596 Business Reg No. (BRN)
68100579
Incorporation Date 2017-08-22 Company Category Private company limited by shares
Current Legal Status Live Statutory Filing Cycle
2027-08-22(2026 Return Filed)
Registered Office Address
ROOM 2102, 21/F, SHUN TAK CENTRE, 168-200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN, HONG KONGShun Tak Centre · View Co-Located Entities →
Significant Controllers (SCR) Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)

#Filing DateDocument No.Document NamePagesTariffAction
12026-08-2522903113369
NAR1
Annual Return (2026) (English)Latest Shareholders & Directors
9HK$ 28
22025-09-0522102048861
ND2B
Notice of Change of Company Secretary and Director (Particulars) (English)
3HK$ 20
32025-08-2223402414803
NAR1
Annual Return (2025) (English)
9HK$ 28
42025-08-1824001903024
ND2A
Notice of Change of Company Secretary and Director (English)
4HK$ 20
52025-03-1923602099701
NR1
Notice of Change of Address of Registered Office (English)
1HK$ 20
62024-10-0222502435652
NAR1
Annual Return (2024) (English)
10HK$ 28
72024-05-1723700853751
NR1
Notice of Change of Address of Registered Office (English)
1HK$ 20
82023-12-27SH000818775
BRN_REF
Reference Document for Business Registration Number as UBI
1HK$ 30
92023-11-2322001475703
ND2B
Notice of Change of Company Secretary and Director (Particulars) (English)
3HK$ 20
102023-10-1122302350254
ND4
Notice of Resignation of Company Secretary and Director (English)
2HK$ 20

III. Commercial Due Diligence & Regulatory Risk Screening

Statutory Licences (32 Regulators) Standard Entity
No statutory licences registered under 32 Hong Kong regulators (Standard Commercial Corp).
Court Litigation & Winding-Up 1 Court Docket on File
Judicial screening across Hong Kong court dockets and the Official Receiver's Office (ORO) identifies 1 public court docket(s) associated with this entity; confirmed no compulsory winding-up petitions (HCCW) on file.
Regulatory Disciplinary & Alert Lists Clean Record
Screen official gazettes, HKMA alert lists, TCSP disciplinary notices, SFC enforcement actions, and customs compliance lists. No negative enforcement records found.
Office & Address Verification Address Resolved
ROOM 2102, 21/F, SHUN TAK CENTRE, 168-200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN, HONG KONG
Statutory Office under Cap. 622 Need Registered Office & Secretary? →

IV. Corporate Statutory Dossier & Legal Status FAQ

Yes. NT Pharma Pacific Company Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2017-08-22 (operating for 9 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: October 2026).

The statutory primary identifiers for NT Pharma Pacific Company Limited are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [68100579] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [2569596] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

Yes. Statutory indexing confirms that NT Pharma Pacific Company Limited has accumulated 24 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2026-08-25: Form NAR1 - Annual Return (2026) (English)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Cross-referenced across Hong Kong statutory regulatory registers (including HKMA, SFC, Companies Registry TCSP, Customs MSO/DPMS, and Insurance Authority IA), this entity holds no special statutory financial licence, operating as a general commercial corporation; 2. Judicial Screening (Litigation & Winding-Up): public court records screening identified 1 public court docket(s) associated with this corporation; confirmed no compulsory winding-up petitions (HCCW) on file. Specific court levels (High Court HCA / District Court DCCJ), case numbers, party capacities, and judgments are accessible via official Due Diligence Reports.

The statutory registered office of NT Pharma Pacific Company Limited on official record is situated at: [ROOM 2102, 21/F, SHUN TAK CENTRE, 168-200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN, HONG KONG]. Official registry dossiers also record 3 statutory registered office address change filing(s) (Form NR1). Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.

Retrieve Filings